IAN
GSK icon

Integrated Advisors Network’s GSK GSK Stock Holding History

Integrated Advisors Network’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Sell
6,494
-733
-10% -$38.8K 0.02% 536
2026
Q1 		$399K Sell
7,227
-1,311
-15% -$71K 0.02% 499
2025
Q4 		$419K Sell
8,538
-1,205
-12% -$56.2K 0.02% 514
2025
Q3 		$420K Buy
9,743
+943
+11% +$36.8K 0.02% 546
2025
Q2 		$338K Sell
8,800
-914
-9% -$34.9K 0.02% 589
2025
Q1 		$376K Buy
9,714
+625
+7% +$22.9K 0.02% 528
2024
Q4 		$308K Sell
9,089
-2,876
-24% -$104K 0.01% 563
2024
Q3 		$489K Sell
11,965
-113
-0.9% -$4.62K 0.02% 477
2024
Q2 		$465K Buy
12,078
+381
+3% +$16K 0.02% 466
2024
Q1 		$502K Buy
11,697
+1,910
+20% +$78.8K 0.03% 465
2023
Q4 		$363K Buy
9,787
+1,265
+15% +$45.4K 0.02% 514
2023
Q3 		$309K Sell
8,522
-1
-0% -$35 0.02% 530
2023
Q2 		$304K Buy
8,523
+66
+0.8% +$2.37K 0.02% 536
2023
Q1 		$301K Buy
8,457
+2,170
+35% +$75.9K 0.02% 544
2022
Q4 		$221K Buy
+6,287
New +$209K 0.01% 572
2022
Q3 		– Sell
-86,666
Closed -$4.72M – 672
2022
Q2 		$4.72M Buy
86,666
+20,126
+30% +$1.11M 0.31% 89
2022
Q1 		$3.62M Buy
66,540
+61,542
+1,231% +$3.34M 0.21% 122
2021
Q4 		$276K Buy
4,998
+300
+6% +$15.6K 0.02% 545
2021
Q3 		$224K Buy
+4,698
New +$236K 0.01% 564
2020
Q4 		– Sell
-4,829
Closed -$227K – 508
2020
Q3 		$227K Sell
4,829
-2,250
-32% -$113K 0.03% 397
2020
Q2 		$361K Buy
7,079
+2,172
+44% +$111K 0.04% 308
2020
Q1 		$232K Sell
4,907
-37
-0.7% -$1.97K 0.05% 319
2019
Q4 		$290K Buy
+4,944
New +$275K 0.04% 331

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Integrated Advisors Network's GSK Position: Q2 2026 in Review

Integrated Advisors Network reduced its GSK (GSK) stake by 10% in Q2 2026, selling an estimated $38.8K and leaving 6,494 shares worth $340K. The position accounts for 0.02% of the portfolio, ranked #536.

Integrated Advisors Network first reported a position in GSK in Q4 2019 and has held it in 23 quarters since. The position peaked at $4.72M in Q2 2022. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Integrated Advisors Network held 6,494 shares of GSK worth $340K as of Q2 2026.
  • Integrated Advisors Network sold 733 GSK shares in Q2 2026, an estimated $38.8K.
  • GSK made up 0.02% of Integrated Advisors Network's portfolio in Q2 2026, its #536 holding.
  • Integrated Advisors Network first reported a position in GSK in Q4 2019 and has held it in 23 quarters since.
  • Integrated Advisors Network's GSK position peaked at $4.72M in Q2 2022.
  • 1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Integrated Advisors Network's 13F filing for Q2 2026, filed 11 Aug 2026.